The refurbishment provides enhanced glass melting power, improved glass distribution, and the production of transparent and amber type I glass bottles to meet the increase in demand for glass vials for vaccines and life-saving medicines.
On June 29, 2020, Bormioli Pharma, an Italian packaging solutions company, announced it has completed the refurbishment of its glass furnace in San Vito al Tagliamento, Italy.
According to a company press release, the refurbishment provides enhanced glass melting power, improved glass distribution, and the production of transparent and amber type I glass bottles to meet the increase in demand for glass vials for vaccines and life-saving medicines. It will also lessen the environmental impact of the plant while adhering to new European sustainability protection policies.
"Thanks to these new investments, we have consistently increased our industrial capacity on glass pharma packaging production, whilst strengthening our capability to provide a complete packaging solution for injectable drugs," said Andrea Lodetti, CEO at Bormioli Pharma, in the press release. "We are proud to be able to support more and better our partners in the pharma industry, helping to bring essential drugs and therapies where they’re needed the most, especially during these challenging times.”
Source: Bormioli
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.